Antibody-mediated Transplant Rejection
📧 Sign up to get email alerts when something new happens for Antibody-mediated Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Bortezomib in Rejection of Kidney Transplants [Phase 2]
Phase 2 trial evaluating bortezomib for chronic antibody-mediated rejection in kidney transplants has completed.